Clinical Trial Update: Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update shows efficacy and safety data for Acoziborole (SCYX-7158) in Gambiense human African trypanosomiasis, with results posted after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gambiense Human African Trypanosomiasis
• Human African Trypanosomiasis

Drugs mentioned

• Acoziborole (acoziborole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Trypanosomiasis, African, Gambiense Trypanosomiasis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-09-17